Wound Infection
3
Pipeline Programs
3
Companies
1
Clinical Trials
2
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
3
Early DiscoveryClinical DevelopmentMarket
On Market (2)
Approved therapies currently available
U
CUBICINApproved
daptomycin
Unknown Companyintravenous2003
U
CUBICIN RFApproved
daptomycin
Unknown Companyintravenous2003
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
NovartisDaptomycin
Clinical Trials (1)
Total enrollment: 650 patients across 1 trials
Daptomycin as Antibiotic Prophylaxis of Sternal Wound Infections
Start: Nov 2008Est. completion: Mar 2012650 patients
Phase 4Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space